Our Blog / the diabetes online community on accuracy

With Dr Klonoff’s blessings we are happy to share information about this Diabetes Technology Society meeting:



Dr. David Klonoff invites you to attend the

Hospital Diabetes Meeting

May 13, 2014

Hyatt Arlington, Arlington, Virginia


Point of Care Blood Glucose Monitors (POC BGMs) are currently being used for purposes other than those cleared by the FDA, such as for acutely ill hospitalized patients in the ICU, OR, Recovery Room, and ER.  Centers for Medicare and Medicaid Services (CMS) has recently announced that in the event of off-label use of POC BGMs in acute care settings these devices will default to high complexity.  The laboratory or manufacturer will then need to validate their devices for these off-label uses per CLIA requirements for high complexity testing.  Many hospitals and manufacturers have stated that this testing/training/staffing/validating process is onerous and they are not planning to participate.  Because of this impasse, we are about to see POC BGMs become no longer permitted in acute care settings of most US hospitals.

Diabetes Technology Society believes that eliminating current POC BGMs from acute care settings of hospitals would be detrimental to patient care. The purpose of this meeting is to explore the role of POC BGMs in the acute care settings of hospitals and find a balance between protecting patients, treating patients, regulating safety, and managing POC testing procedures. We will seek to identify the true benefits of his technology, alternate approaches to measuring BG in acute care settings, and practical methods to validate POC BGM performance so that hospitals and/or companies will be willing and able to validate.

The 2014 Hospital Diabetes Meeting on May 13, 2014 at the Hyatt Arlington will bring together leading clinicians from endocrinology, hospital medicine, surgery, anesthesiology, nursing, and clinical chemistry along with regulators from CMS, FDA and the Joint Commission to reach a consensus about the role of POC BGMs in acute care settings and what tools are needed to monitor BG levels in such settings.  We are also soliciting comments from the public.

This timely meeting is open to anyone at no charge, but registration is required and space is limited.  You may register at: <www.diabetestechnology.org/hospital/>

I look forward to seeing you in Arlington,


David Klonoff, MD, FACP, Fellow AIMBE, Chair
Clinical Professor of Medicine, UCSF
President, Diabetes Technology Society
San Francisco, California, USA

Diabetes Technology Society 
1157 Chess Drive, Suite 100 • Foster City, CA 94404


Bennet Dunlap

So, what do you think ?